Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function

Majid Iqbal1, Vasilis G Moisiadis, Alisa Kostaki

  • 1Department of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8.

Endocrinology
|May 9, 2012
PubMed

Insights

Prenatal synthetic glucocorticoid (sGC) exposure alters hypothalamic-pituitary-adrenal (HPA) axis function and behavior in second-generation offspring. These effects suggest long-term impacts on stress response and hormonal regulation across generations.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Neuroscience

Background:

  • Synthetic glucocorticoids (sGC) are used to promote fetal lung development in pregnancies at risk of preterm delivery.
  • Prenatal sGC exposure has been shown to affect hypothalamic-pituitary-adrenal (HPA) axis function in first-generation (F(1)) offspring.

Purpose of the Study:

  • To investigate whether prenatal sGC exposure impacts HPA function and behavior in the subsequent (F(2)) generation.
  • To assess the long-term consequences of maternal sGC treatment on offspring HPA axis regulation and behavior.

Main Methods:

  • Pregnant guinea pigs (F(0)) were administered betamethasone (BETA) or saline during gestation.
  • F(1) females were mated to produce F(2) offspring, whose HPA function and behavior were assessed.
  • HPA axis function was evaluated through stress responses and dexamethasone suppression tests.
  • Gene expression analysis of HPA-related components was performed in adult F(2) offspring.

Main Results:

  • F(2) offspring exposed prenatally to BETA exhibited reduced locomotor activity (males) and blunted cortisol responses to stress.
  • Differential effects on negative feedback regulation were observed in F(2) males and females following dexamethasone challenge.
  • F(2) BETA females showed reduced pituitary proopiomelanocortin and corticotropin-releasing hormone receptor expression.
  • Altered hippocampal glucocorticoid receptor expression was noted in both F(2) BETA males and females.

Conclusions:

  • Prenatal betamethasone treatment has lasting effects on HPA axis function and behavior in F(2) offspring.
  • Pituitary function is primarily affected in F(2) females, while hippocampal feedback systems are altered in both sexes.
  • These findings highlight potential transgenerational impacts of synthetic glucocorticoid therapy used in preterm labor management.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...